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Fungal colonization with Pneumocystis is associated with increased airway mucus in infants during their
primary Pneumocystis infection, and to severity of COPD in adults. The pathogenic mechanisms are under
investigation. Interestingly, increased levels of hCLCA1 – a member of the calcium-sensitive chloride
conductance family of proteins that drives mucus hypersecretion – have been associated with increased
mucus production in patients diagnosed with COPD and in immunocompetent rodents with Pneumo-
cystis infection. Pneumocystis is highly prevalent in infants; therefore, the contribution of Pneumocystis to
hCLCA1 expression was examined in autopsied infant lungs. Respiratory viruses that may potentially
increase mucus, were also examined. hCLCA1 expression was measured using actin-normalized Western-
blot, and the burden of Pneumocystis organisms was quantiﬁed by qPCR in 55 autopsied lungs from
apparently healthy infants who died in the community. Respiratory viruses were diagnosed using RT-PCR
for RSV, metapneumovirus, inﬂuenza, and parainﬂuenza viruses; and by PCR for adenovirus. hCLCA1
levels in virus positive samples were comparable to those in virus-negative samples. An association
between Pneumocystis and increased hCLCA1 expression was documented (P¼0.028). Additionally,
increasing Pneumocystis burden correlated with increasing hCLCA1 protein expression levels (P¼0.017).
Results strengthen the evidence of Pneumocystis-associated up-regulation of mucus-related airway
responses in infant lungs. Further characterization of this immunocompetent host-Pneumocystis-
interaction, including assessment of potential clinical signiﬁcance, is warranted.
& 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).1. Introduction
Mild and asymptomatic infections by the fungal pathogen
Pneumocystis are of uncertain pathological signiﬁcance. They are
known as “Pneumocystis colonization” and are highly frequent in
normal immunocompetent infants and adults [1]. Recent evidence
of Pneumocystis-related pathology in immunocompetent infants
with histologically mild and asymptomatic Pneumocystis infection,
was provided by documenting increased protein levels of the
goblet cell mucin MUC5AC, a marker of mucus, associated with
Pneumocystis in autopsied lungs of infants who died in the
community with an autopsy diagnosis compatible with Sudden
Unexpected Infant Death (SUID) [2]. Mucus is widely recognized as
an aggravating factor of respiratory illnesses, including chronicr B.V. This is an open access article
).obstructive pulmonary disease (COPD), where Pneumocystis has
been associated with increased disease severity [3]. Therefore, the
documentation of Pneumocystis-related mucus pathology in infant
lungs warrants continued research to elucidate whether Pneumo-
cystis plays a role in the increased respiratory morbidity of infants
characteristic of this age group [2].
Mucus production is stimulated through several intracellular
pathways still under investigation; one proposed pathway is
mediated by chloride channel accessory 1 (hCLCA1), a member
of the calcium-sensitive chloride conductance (CLCA) family of
genes, whose expression is increased in human airways of asth-
matic and COPD patients [4–9]. In general, CLCA proteins mediate
airway epithelium immune responses inducing mucous cell me-
taplasia and airway hyperreactivity [6,7]. More speciﬁcally, it has
been documented in cell culture models, that mClca3/hCLCA1
stimulates mucus (MUC5AC) production [7,10]. In addition, it has
been shown in mouse models, and in human and rodent primaryunder the CC BY license (http://creativecommons.org/licenses/by/3.0/).
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Stat6-dependent pathway [8].
Important insight into the role of Pneumocystis in this pathway
has been gained through studies using immunocompetent mouse
models which showed that mClCa3 (or Gob5), the murine homolog
of hCLCA1, is signiﬁcantly increased in association with Pneumo-
cystis[11] . In addition, it has been documented more recently that
Pneumocystis can induce STAT6-dependent pathways eliciting
mouse-strain-dependent responses [12]. The link between CLCA
proteins and mucus overproduction is well reported in animal
models [6,7]. Studies in infant lungs would be ideal for under-
standing the link between Pneumocystis colonization and mucus
overproduction recently reported in infants [2,13]. Moreover, since
respiratory viruses are recognized agents of increased mucus
production [4] and because their relative contribution to hCLCA1
and MUC5AC with respect to Pneumocystis in infant lung samples
remains unknown, we also evaluated the presence of common
respiratory viruses in infant lungs in this study.2. Materials and methods
2.1. Subjects and samples
The study, approved by the Ethics Committees of the North
Metropolitan Area of Health and of the University of Chile School
of Medicine in Santiago, was retrospectively conducted in fresh-
frozen stored infant lung specimens previously categorized as
Pneumocystis negative or positive, blinded to autopsy diagnosis
and date of death, by microscopy and n-PCR. Samples were age
matched and a 1:2 (negative:positive) ratio was used. They
corresponded to 55 legally-required infant autopsies conducted
between 1999 and 2004 at the Servicio Medico Legal, the coroner’s
ofﬁce in Santiago. Samples stored at 80 °C, were selected from
18 Pneumocystis-negative and 37 Pneumocystis-positive infants
with sufﬁcient tissue left for analyses. Their mean age was 3.19
(1.0–11.9) months; all had died suddenly and unexpectedly (SUID)
in the community without hospitalization [2]. One gram of deep
lung tissue was extracted with all possible sterile precautions
inside a laminar ﬂow biosafety cabinet, ﬂash-frozen pulverized inFig. 1. Pneumocystis-associated increased expression of hCLCA1 (P¼0.0280). Wes-
tern blot determinations performed in fresh-frozen homogenized autopsy lung
samples from Pneumocystis-positive (n¼37) and Pneumocystis-negative (n¼18)
infants. Data are presented as median interquartile range. hCLCA1 expression levels
were analyzed using Mann–Whitney test. Signiﬁcance was deﬁned as Po0.05.liquid nitrogen using a mortar and pestle, homogenized, and
frozen at 80 °C until nPCR was repeated to re-conﬁrm their
Pneumocystis jirovecii-status. Quantitative PCR (qPCR) for P. jirove-
cii was performed on all P. jirovecii-positive samples; Reverse
Transcription PCR (RT-PCR) or PCR for respiratory viruses, and
Western blot analyses of hCLCA1 were also performed.
2.2. Pneumocystis and virus determinations
Pneumocystis status of samples was re-conﬁrmed using a
nested-PCR speciﬁc for P. jirovecii as described [2]. Total DNA
extraction was performed using QIAampsDNA Minikit (Qiagen,
Valencia, CA, USA). RNA was extracted using Trizol reagent
(Invitrogen, CA, USA) according to the manufacture’s instructions.
P. jirovecii burden was quantiﬁed by qPCR amplifying the human
Pneumocystis GpA/MSG gene with speciﬁc primers and probe (5′ d
FAM-TGCAAACCAACCAAGTGTACGACAGG-BHQ-1 3′) as described
[14,15]. These probe quantiﬁcations were compared with Pneumo-
cystis SYBR green quantiﬁcations of the same specimens in our
previous study [2]. cDNAs were synthesized to identify Respiratory
Syncytial Virus (RSV), Inﬂuenza A and B, Parainﬂuenza virus 1, 2,
and 3, and Metapneumovirus, by RT-PCR with speciﬁc primers
[16–19]. Total DNA was used to evaluate Adenovirus by PCR as
described [20]. Viral positive controls were additionally conﬁrmed
using standard diagnostic immunoﬂuorescence microscopy. Bac-
terial cultures are not considered as part of the legal autopsy
protocol, and were not done because the samples were received
after 24 h post-mortem [2].
2.3. hCLCA1 determinations
Samples for hCLCA1 determinations were processed as de-
scribed, unless stated otherwise. Western blot were performed
from 30 mg protein aliquots, using SDS-PAGE 12% polyacrylamide
resolving gels. hCLCA1 was detected using mouse anti-hCLCA1 IgG
(1:500 sc-271156, Santa Cruz, USA). Measured values were nor-
malized by human actin-gene expression for inter-sample
comparison.
2.4. Statistical analyses
GraphPad Prism 5 software (San Diego, CA, USA) was used for
analysis. Comparisons between normalized levels of hCLCA1
protein expression values according to the presence of Pneumo-
cystis or of viruses were performed using Mann–Whitney. The
correlation between hCLCA1 protein levels with Pneumocystis
GpA/MSG copies was done using the Spearman test. A P value of
o0.05 was considered signiﬁcant.3. Results
All selected infants were conﬁrmed to have died suddenly and
unexpectedly at home and without being hospitalized, indicating
that Pneumocystis infection in themwas mild. P. jirovecii diagnostic
status was also re-conﬁrmed by n-PCR in the 37 Pneumocystis-
positive and 18 Pneumocystis-negative infants. Mean Pneumocystis
burden, as determined using the probe method, was 10,119 (1–
299,697; median 120) GpA/MSG copies/ng human DNA. Pneumo-
cystis burden determinations using SYBR Green method, reported
in a previous study on these same samples [2], were concordant
with the probe method determinations in this study.
Analysis of protein extracts documented a signiﬁcant increase
in normalized expression levels of hCLCA1 in Pneumocystis-posi-
tive samples compared to Pneumocystis-negative samples
(P¼0.0280) (Fig. 1), suggesting that Pneumocystis is associated
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mucus-related responses.
The contribution of Pneumocystis burden to the expression of
hCLCA1, as analyzed by correlation protein expression graphics,
detected a signiﬁcant positive correlation between increasing levels
of hCLCA1 and Pneumocystis burden suggesting induction by Pneu-
mocystis (Spearman r¼0.3479; P¼0.0171) (Fig. 2). Common respira-
tory viruses were studied in Pneumocystis-positive and Pneumocystis-
negative samples to assess their contribution to hCLCA1 expression
levels. Respiratory Syncytial Virus was diagnosed in three and
Adenovirus in one of the Pneumocystis-positive samples. No viruses
were detected in the Pneumocystis-negative samples (Fig. 3). Protein
expression levels of hCLCA1 were no different in virus-positive
compared to virus-negative samples indicating that, in these samples,
viruses do not explain the Pneumocystis-associated increased levels of
this protein. Moreover, virus positive samples were grouped for this
comparative analysis, and no signiﬁcant difference in hCLCA1 expres-
sion was detected between virus-positive and virus-negative samples
(P¼0.7648) (Fig. 3).4. Discussion
The increased hCLCA1 protein levels associated with Pneumo-
cystis in infant lungs documented in this study provide additional
evidence that Pneumocystis infection is associated with stimula-
tion of the respiratory epithelium mucus-secretion-system in non-Fig. 2. hCLCA1 expression positively correlates with Pneumocystis organism’s load
(Spearman rs¼0.34785; P¼0.0171). Correlation graph of hCLCA1 protein expres-
sion levels compared with Pneumocystis burden as determined by qPCR. Linear
regression was performed and the ﬁtted line is showed on the graph. Broken lines
represent 95% conﬁdence intervals.
Fig. 3. (A) Effect of viral co-infection on hCLCA1 protein expression in Pneumocystis-po
represent adenovirus. Horizontal black lines represent median values. (B) Expression of h
(n¼51). Mann–Whitney test. Signiﬁcance was deﬁned as po0.05.immunocompromised humans (Fig. 1). Furthermore, all infants in
this study were mostly asymptomatic prior to death revealing the
mild nature of this Pneumocystis infection, which is consistent
with a state of symptomless “colonization”. An association be-
tween increased levels of the goblet cell mucin MUC5AC and
Pneumocystis was reported in a previous study [2], and the
association between hCLCA1 and MUC5AC, which is well-docu-
mented in animal models, has been recently reported in patients
diagnosed with COPD [21].
Results also document that an increasing burden of Pneumo-
cystis is correlated with increasing levels of hCLCA1 protein
expression, suggesting a Pneumocystis-related, stimulatory effect
on hCLCA1 induction (Fig. 2) [6,8]. Overexpression of hCLCA1 may
explain the increase in mucus proteins, such as MUC5AC, asso-
ciated with Pneumocystis through stimulation of the STAT6–
hCLCA1–MUC5AC proposed pathway [7]. Pneumocystis is a slowly
replicating fungus that may likely require days or even weeks to
induce an effective T-cell lymphocytic response capable of clearing
Pneumocystis from the lungs, therefore allowing time for pro-
longed stimulation of the respiratory epithelium and to induce the
expression of mClca3/Gob5 documented in rodents [11], and of
hCLCA1 in this study in humans. Importantly, the induction of
STAT6-dependent pathways by Pneumocystis recently documented
in rodents can result in clinico-pathological consequences, includ-
ing Pneumocystis-induced airway hyperresponsiveness (AHR) [12],
therefore underscoring the need for further study of these me-
chanisms in human lungs.
Mucus-associated up-regulation by Pneumocystis may be theo-
retically relevant in different scenarios. For example, as a co-factor
in increasing severity of respiratory illnesses during infancy, when
narrow developing airways are present. Pneumocystis colonization
is highly prevalent in infants, affecting over 90% of infants between
2 and 5 months of age, when respiratory morbidity typically
increases [2]. Results may also strengthen the association between
Pneumocystis and severity of COPD [3]; a disease that is strongly
associated with increased mucus compromising narrow airways in
immunocompetent adults [4,21,22]. Overexpression of mClca3
induces mucous cell metaplasia, airway hyperreactivity (AHR)
and increased airway resistance in immunocompetent rodents,
and is also correlated with increased MUC5AC levels [6,7]. Recent
studies using microarray technology on lung samples from pa-
tients diagnosed with COPD found Pneumocystis-related overex-
pression of proteins that are predominantly expressed on activated
Th 1 T-lymphocytes showing the complexity of this Pneumocystis
host interaction [23]. A more complete characterization of the
immune response to Pneumocystis in these infants might lead tositive infant lung samples. Thin open circles represent RSV and thick open circles
CLCA1 protein in virus-positive samples (n¼4) compared to virus-negative samples
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respiratory viruses are associated with mucus hypersecretion,
including increased expression of MUC5AC [4,6,7]. Therefore, we
were expecting to detect an additive increase of hCLCA1 in
samples where Pneumocystis and viruses were associated. Unfor-
tunately, the limited number of virus-positive specimens detected
using DNA/RNA ampliﬁcation techniques in this study precluded
us from identifying any relationship between common respiratory
viruses and increased hCLCA1 or MUC5AC. The 20% pooled
detection rate for viruses is similar to previous studies published
by our group on autopsied infant lungs using viral cultures and
immunoﬂuorescence [24]. Pneumocystis is highly endemic in
infants, while viruses follow epidemic patterns. Viruses are of
low prevalence in these type of infant samples [25]. The viruses
that were examined in these samples were the same as previously
identiﬁed using other techniques [24]. Of note, hCLCA1 (and
MUC5AC; data not shown) determination values in the virus-
positive specimens of this study were close to average, and
therefore indicate that viruses do not explain the increased
expression of these proteins associated with Pneumocystis in
infants (Fig. 3).
In summary, results show that the primary infection by
Pneumocystis may play a role in up-regulating airway mucus-
related responses in non-immunosuppressed infants through in-
duction of an hCLCA1-related pathway. These type of responses
may affect lung function, as shown in rodents, therefore suggest-
ing that up-regulated airway epithelium innate responses may be
clinically relevant to infants and the general population in differ-
ent clinical scenarios where Pneumocystis is common. Further
research to elucidate hCLCA1-related pathways associated with
Pneumocystis infection in humans, and to assess the potential
impact of Pneumocystis asymptomatic infection in respiratory
disease of the immunocompetent host, is warranted.Acknowledgements
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